Dr. Osorio is a innovative businessman with an distinct entrepreneurial mindset concentrated in adding value on the areas of Biotechnology (mRNA), Reprogramming & Regenerative Medicine for translational use in humans and a variety of clinical applications aimed for both the private and the public health sectors. He is the CEO of RegenerAge Clinic and RegenerAge Beauty. VP and Clinical Developer for Bioquark, Inc., CCO at Reanima Advance Biosciences Project. President at Dr. Jois an anti-aging, beauty, and cosmetic products endorsement company. VP and Chairman of the WAMS Americas Division. Earned MD degree at Westhill University. Diplomate in aesthetic medicine (UAG), Advance Fellow by the ABAARM, visiting scholar at UNC at Chapel Hill in Dermatology. Fellow in Stem Cell Medicine by the A4M and USF, Business Diplomate at ECA, enrolled Master on Health Sciences at Victoria University. Has appeared on several occasions on International media, some of his latest broadcast appearances are CNN español, TV Azteca, Excelsior Newspaper, Medicable, PharmaBoard Room, and Podcasts among others. His public appearances as a speaker at the 2018 RAADfest (San Diego), 3rd International Conference on Molecular Medicine and Diagnostics (Dubai), Global Academic Business Forum on Tissue Engineering and Regenerative Medicine (Baltimore), Second International Congress on mHealth (Shiraz), 6th International Conference on Tissue Engineering and Regenerative Medicine (S.F), 11th World Congress on Cell & Tissue Science (Tokyo), 17th International Conference on Neurology and Neuroscience (Toronto), 9th International Conference & Exhibition on Tissue Science and Regenerative Medicine (Las Vegas) among others, makes him a pioneer on the Regenerative+Reprogramming Medicine Field. His passion for football, brought as a result the Dr.Jois Foundation A.C aimed at helping those American football athletes who have sustained injury get another chance through the Regenerative & Reprogramming Medicine.
Professor Fariba Dehghani leads a multidisciplinary bioengineering research team comprising engineers, scientists, clinicians and molecular biologists focused on developing technologies for nutritional food products and biomaterials, with particular emphasis on tissue engineering and regenerative medicine. She is one of the members of ARC College of Expert, the director of Australian Research Council for Australian Food Processing Industry in the 21st Century, as well as director of Centre of Excellence in Advanced Food Enginomics in the Faculty of Engineering and Information Technologies at the University of Sydney. Professor Dehghani is a distinguished researcher and was recognised by Engineers Australia as one of the nation's top 50 Engineers for innovation. She subsequently received the 2017 Award for Excellence from Aust &NZ Federation of Chemical Engineering. She has been instrumental in building a multidisciplinary research environment that stimulates the interface and intersect of engineering, science, medicine, pharmacy and agriculture. She has established long-term collaborations within the biotech, biomed and food industries and acquired substantive funding from national and international funding agencies.
Professor Fariba Dehghani’s research in bioengineering focuses on developing technologies for processing biomaterials, with particular emphasis on tissue engineering and regenerative medicine.
Steven Haken’s background consists of 25 years’ experience in the healthcare and medical industry in the US, UK and Europe, including general, technical and operations management, strategic planning, marketing and business development. His Corporate Development deal sheet includes many acquisitions, licensing, and partnership agreements. He is a strategic thinker on technology architecture who optimises product roadmaps to maximize outcomes. He is an accomplished entrepreneur, founding, financing and growing several healthcare service organizations.He has clinical and business affiliations with many top-tier University teaching Hospitals in the US and the EU, and with NASA, having negotiated and successfully contracted with many medical device and medical IT multinationals and National Health Service Directors. He has consulted and assisted off-shore medical technology organizations, ranging from start-ups to Fortune 500 companies, in diverse areas including market development, opportunity analysis, regulatory and reimbursement strategies, business development, financing and more.
Dr.Vikrant Sharma completed his Ph.D. in Electronics & Communication Engineering from I.K. Gujral Punjab Technical University, Jalandhar and currently working as Professor and Dean at GNA university, Phagwara, Punjab. His area of interest is Optical fiber and Communication systems. He has more than 18 years of teaching experience in both theory and practical. He has more than 60 plus publications. He has presented his paper at both national and international conferences such as BEAT-2010, RIET-2012, IEFT-2014, IMTC-2014, ISF 2015 at University of Oxford. He is the recipient of several awards such as PIT Crew Award by Alabama (NASA), ISTE section best-emerging chapter award, Best Ph.D. dissertation award. He is also a lifetime member of ISTE and IETE. His has a keen research interest in Optical fiber and Biosensors.
Dr Sergey Suchkov, MD, PhD. Professor in Immunology & Medicine. Director, Center for Personalized Medicine, Sechenov University and Chair,Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Born on 11 Jan 1957, Astrakhan, Russia; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M.Sechenov First Moscow State Medical University, 1985; Doctor Degree, National Institute of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Institute of Medical Enzymology; Head of the Lab of Immunology, Helmholtz Eye Research Institute in Moscow; Trainee, Laboratory of Immunology, NEI, Bethesda, MD, USA; Chair, Department for Clinical Immunology, Moscow Clinical Research Institute; Executive Secretary-in-Chief of the Editorial Board, Biomedical Science International journal. Honours: Secretary General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; ISPM, Tokyo, Japan; PMC, Washington, DC, USA; ACS, USA; AMEE, Dundee, UK; AHA, USA; EPMA, Brussels.
Dr. Pongsak Rattanachaikunsopon is a Professor in the Department of Biological Science at University of Ubon Ratchathani, Thailand. He obtained Bachelor of Science in Radiological Technology at Mahidol University, Thailand and a Master of Science in Anatomy at Mahidol University, Thailand. He earned Ph.D. in Molecular Biology at Lehigh University, Pennsylvania USA. He has been awarded with Professor Sood Saengvichain Award for Best Research and Presentation in 13th Annual Meeting of the Society of Anatomy of Thailand in 1990, Professor Dr. Tab Nilanidhi Foundation Award for the outstanding graduate student in Anatomy in 1991 and Best Government Officer, The Ministry of Education in 2014. He serves as an Editorial board member of more than 10 international Journals
Molecular Biology, Microbiology and Biochemistry
Henry M. Sobell completed his studies at Brooklyn Technical High School (1948-1952), Columbia College (1952-1956), and the University of Virginia School of Medicine (1956-1960). Instead of practicing clinical medicine, he then went to the Massachusetts Institute of Technology (MIT) to join Professor Alexander Rich in the Department of Biology (1960-1965), where, as a Helen Hay Whitney Postdoctoral Fellow, he learned the technique of single crystal X-ray analysis. He then joined the Chemistry Department at the University of Rochester, having been subsequently jointly appointed to both the Chemistry and Molecular Biophysics departments (the latter at the University of Rochester School of Medicine and Dentistry), becoming a full tenured Professor in both departments (1965-1993).He is now retired and living in the Adirondacks in New York, USA.
Ondarza has had extensive experience in teaching biochemistry and molecular biology to students of Biology and Medicine, in the Faculties of Sciences and Medicine of the UNAM. His experience includes directing research theses and providing formal courses for students in both Master's and Doctor's degree programs. For twelve years, Dr. Ondarza was Advisor and General Coordinator of Science Committees within CONACYT (1971-1982) and created five new research centers in several locations in Mexico dedicated to the fields of Ecology, Biomedical Research, Biotechnology, Chemistry, Marine Biology and Oceanography. These centers are CICESE in Ensenada, B.C.; CIBNOR in La Paz, B.C. Sur; CIES in San Cristobal de Las Casas, Chiapas; CIQA in Saltillo, Coahuila; and CICY in Merida, Yucatan. Ondarza has been 'Director of Research' on three separate occasions: The first for a period of seven years (1983-1989) as General Director in the Center of Ecological Research in San Cristobal de las Casas, Chiapas. This center is dedicated to studies of the biomedical, socioeconomic and agro-ecological problems of the South East of Mexico. The second activity was in the Foreign Affairs Secretariat of the Government of Mexico, where he acted as General Director of Scientific and Technological Cooperation (1990). Among the various international agreements of collaboration with Europe and Central America, he signed the Agreement between USA and Mexico, in the Campus of the University of California at San Diego in La Jolla. The third experience was as Director of the Center of Research for Infectious Diseases, National Institute of Public Health in Cuernavaca, Morelos, for the three-year period 1990-93. Actually Ondarza's interests are in the biochemistry and molecular biology of human parasites, as well as in cancer cells infected by the Papilloma virus. These studies are all relevant to the concept of the discovery of new compounds which are unique to these parasites and also for the related enzymes that can serve as 'drug targets'. This approach will permit the discovery of specific drugs that do not affect the human host. He has received the following Distinctions. British Council Scholar, Postgraduate studies in Biochemistry, Glasgow University, Scotland, Great Britain, 1953-54. Chairman Professor James N. Davidson. Scholarship from the Organization of The American States (OAS) to study and do research on Streptococcus pneumonia, Downstate Medical Center, New York State University, Brooklyn, USA, 1959. Chairmen, George T. Mills and Evelyn E.B. Smith. Doctor in Biology (Biochemistry) Faculty of Sciences Universidad Nacional Autonoma de Mexico, December 1963. Fellow John Simon Guggenheim Memorial Foundation, 1963. Dr. Honoris Causa, Republique Francaise, Ministere de l'Education Nationale, Academie de Creteil, Universite Paris Xlll (1984). Visiting Professor in four occasions, at Scripps Institution of Oceanography, University of California, San Diego at La Jolla, California, School of Science and Engineering; during his first sabbatical year, 1964. Chairman Professor David Bonner; during his second sabbatical, 1982, Chairman Professor Andrew Benson; during his third sabbatical, 2002, Chairman Professor William Fenical; during his fourth sabbatical year, 2005, Chairman Professor William Fenical and Visiting Researcher, Department of Chemistry, University of California, San Diego, at La Jolla, 1986. Professor Robert C. Fahey. Carnot Prize, Gold Medal and Diploma, National Academy of Medicine, 1968. Prize of the National Chemical-Pharmaceutical Industry, 1971, Diploma. Member of the Symposia Organizing Comitee, International Union of Biochemistry (IUB), from 1971 to 1976. Homage received as 'Founder of the Course of Molecular Biology' in 1963, by students of the generation 62-65 from the Faculty of Sciences, (Actuary, Biology, Physics and Mathematics), October 21,1993, Aula Magna 1, Faculty of Sciences, UNAM, University City.
Ming Pei completed his PhD from Beijing University, China and Postdoc training from Harvard-MIT Division of Health Sciences and Technology, USA. Currently he is a tenured Professor and Director of Stem Cell and Tissue Engineering Laboratory in the Department of Orthopaedics, West Virginia University, USA. He has over 100 publications that have been cited over 3100 times, and his publication H-index is 32 and has been serving as an editorial board member of reputed Journals.
Giulio Tarro graduated from Medicine School, Naples University (1962). He was a Research Associate in the Division of Virology and Cancer Research at Children’s Hospital (1965-1968). He also serverd as a Assistant Professor of Research Pediatrics at Cincinnati University, Ohio. He was a Professor at Naples University (1972-1985). He was seving as a Chief in the Division of Virology (1973-2003) and Head Department Diagnostic Laboratories, (2003-2006). He received recipient of the Sbarro Health Research Organization lifetime achievement award (2010). Currently he ia a President at Foundation de Beaumont Bonelli for Cancer Research.
Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Division & De la Parra Mobile Solutions, while also being the President of PetroM Renewable, VP of Operations & Strategy at PetroM Logistics, both divisions of PetroM Corp. Former COO & Co-founder at RegenerAge® Clinic & RegenerAge® Beauty & a member of the Board of Advisors. Former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging®, What Skin Needs™/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former CMO at ReAnima Advanced Biosciences and former Digital Media Director at Bioquark, Inc. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy. Alejandro De la Parra Solomon is on Google+, Facebook, and on LinkedIn.
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement; include BBC, ITV, WSJ, CNN, and many more. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. He has commercialised a novel functionalised graphene oxide for medical and other industrial applications. He also commercialised new biodegradable nanocomposite materials for medical and other industrial applications. He is British citizen and completed his school in UK (concord college) and his scientific training at London University.